Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON

Wim A. Wuyts; Francesco Bonella; Nazia Chaudhuri; Francesco Varone; Danielle Antin-Ozerkis; Heiko Mueller; Carl Coeck; Klaus B. Rohr; Vincent Cottin

doi:10.1183/13993003.congress-2021.PA2538

Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON

Wim A. Wuyts
, Francesco Bonella
, Nazia Chaudhuri
, Francesco Varone
, Danielle Antin-Ozerkis
, Heiko Mueller
, Carl Coeck
, Klaus B. Rohr
, Vincent Cottin

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	European Respiratory Journal
Volume	58
DOIs	https://doi.org/10.1183/13993003.congress-2021.PA2538
Publication status	Published (in print/issue) - 5 Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Treatments
Orphan diseases

Access to Document

10.1183/13993003.congress-2021.PA2538

Cite this

@article{b17de3c8ebfb4632823613e9923de645,

title = "Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON",

keywords = "Treatments, Orphan diseases",

author = "Wuyts, \{Wim A.\} and Francesco Bonella and Nazia Chaudhuri and Francesco Varone and Danielle Antin-Ozerkis and Heiko Mueller and Carl Coeck and Rohr, \{Klaus B.\} and Vincent Cottin",

year = "2021",

month = sep,

day = "5",

doi = "10.1183/13993003.congress-2021.PA2538",

language = "English",

volume = "58",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

}

TY - JOUR

T1 - Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON

AU - Wuyts, Wim A.

AU - Bonella, Francesco

AU - Chaudhuri, Nazia

AU - Varone, Francesco

AU - Antin-Ozerkis, Danielle

AU - Mueller, Heiko

AU - Coeck, Carl

AU - Rohr, Klaus B.

AU - Cottin, Vincent

PY - 2021/9/5

Y1 - 2021/9/5

KW - Treatments

KW - Orphan diseases

U2 - 10.1183/13993003.congress-2021.PA2538

DO - 10.1183/13993003.congress-2021.PA2538

M3 - Meeting Abstract

SN - 0903-1936

VL - 58

JO - European Respiratory Journal

JF - European Respiratory Journal

ER -